CD 130 (Ranitidine hydrochloride 300 mg)

Pill imprint CD 130 has been identified as Ranitidine hydrochloride 300 mg.

Ranitidine is used in the treatment of gerd; erosive esophagitis; gastric ulcer maintenance treatment; zollinger-ellison syndrome; duodenal ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for CD 130

Ranitidine hydrochloride 300 mg CD 130
Ranitidine hydrochloride
Imprint:
CD
130
Strength:
300 mg
Color:
Brown
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Dr. Reddy’s Laboratories Inc.
National Drug Code (NDC):
55111-0130
Inactive Ingredients:
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
ferrosoferric oxide
ferric oxide red
ferric oxide yellow
titanium dioxide
gelatin
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
49884-0648 Par Pharmaceutical

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)